Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
KEEGO HARBOR, Mich., May 27, 2021 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in
recent post
-
Nov 15 2025 -
Nov 15 2025
-
Nov 15 2025
-
-
Acorns Investing App Going Public in $2.2 Billion SPAC Merger
The company should fuse with Pioneer Merger Corp. in the latter half of this year.
Trade unions in America: The times they are a-changin’
The US labour market is producing too few jobs and those it is producing are often low paid and